BMY 241227 40.00P (BMY241227P40000) Stock Options, News & Quotes

US OptionsDetailed Quotes

BMY241227P40000

Watchlist

0.00
0.000.00%

15min DelayClose Dec 23 09:30 ET

0.00High0.00Low

Intraday

5D
Daily

No Data

News

Schwab US Dividend Equity ETF Reverses In December: What's Going On?
Benzinga15:53 ET
Bristol-Myers Squibb Says Phase 3 Trials of Sotyktu in Psoriatic Arthritis Meets Endpoints
MT NewswiresDec 23 07:38 ET
Bristol Myers Squibb's Sotyktu Shows Results in Psoriatic Arthritis Trials
BenzingaDec 23 07:00 ET
Express News | Bristol-Myers Squibb Co: Sotyktu Was Well-Tolerated and Demonstrated Safety Consistent With Established Profile
ReutersDec 23 06:59 ET
Express News | Bristol-Myers Squibb Co - Phase 3 Trials Met Primary Endpoint With Significant Acr20 Response
ReutersDec 23 06:59 ET
Express News | Bristol Myers Squibb Announces Positive Topline Results From Two Pivotal Phase 3 Trials Evaluating Sotyktu (Deucravacitinib) in Adults With Psoriatic Arthritis
ReutersDec 23 06:59 ET

Comments

Meltyy

Dec 17 01:56

📌 1 PDUFA this weekand 6 more upcoming this month! 🚀

🔔 This Week’s PDUFA:
$Ionis Pharmaceuticals (IONS.US)$ : 🤔
⇨ IONIS-APOCIII-LRx (Olezarsen)
‣ FCS (Familial chylomicronemia syndrome)
‣ PDUFA: 12/19/24 (NDA)
🗓️ Last Week’s PDUFA Decisions:
$Checkpoint Therapeutics (CKPT.US)$ : Approved 12/13/24 ✅
⇨ UNLOXCYT (cosibelimab-ipdl)
‣ metastatic or locally advanced cSCC (cutaneous squamous cell carcinoma)
‣ PDUFA: 12/28/24 (resubmitted BLA)
$Neurocrine Biosciences (NBIX.US)$ : Approved 12/13/24 ✅
⇨ CRENESSITY™ (crin...

10xStockPicks

Dec 15 18:30

A.i Predicts Big Pharma Will Soon Acquire Esperion Therapeutics for $12 to $16 A share, Current Price $2.25

$Esperion Therapeutics (ESPR.US)$ Acquiring Esperion Therapeutics could be a strategic move for a big pharmaceutical company for several compelling reasons. Here are the main factors that suggest an acquisition could be beneficial for a larger player in the pharmaceutical industry:
1. Unique Market Position in Statin Alternatives
– Addressing Statin Intolerance: There are millions of statin...

Meltyy

Dec 10 05:36

🚀 10 Upcoming PDUFAs in December! ❄️

Buckle up! See FDA PDUFA update 👇
$Ionis Pharmaceuticals (IONS.US)$ ⇨ IONIS-APOCIII-LRx (Olezarsen)
$ZLDPF ⇨ Glepaglutide
$Rhythm Pharmaceuticals (RYTM.US)$ ⇨ IMCIVREE™ (Setmelanotide)
$Mirum Pharmaceuticals (MIRM.US)$ ⇨ Chenodal® (chenodiol)
$Checkpoint Therapeutics (CKPT.US)$ ⇨ Cosibelimab (CK-301)
$Neurocrine Biosciences (NBIX.US)$ ⇨ Crinecerfont capsule
$Bristol-Myers Squibb (BMY.US)$ ⇨ Opdivo® Subcutaneous (nivolumab + hyaluronidase)
$Neurocrine Biosciences (NBIX.US)$ ⇨ Crinecerfont oral solution
$BeiGene (BGNE.US)$ ⇨ Tisleli...

Meltyy

Dec 5 06:32

🚀 12 upcoming PDUFAs in December ❄️

Buckle up! See FDA PDUFA update 👇🧵
$Ionis Pharmaceuticals (IONS.US)$ ⇨ IONIS-APOCIII-LRx (Olezarsen)
$ZLDPF ⇨ Glepaglutide
$Rhythm Pharmaceuticals (RYTM.US)$ ⇨ IMCIVREE™ (Setmelanotide)
$Mirum Pharmaceuticals (MIRM.US)$ ⇨ Chenodal® (chenodiol)
$Checkpoint Therapeutics (CKPT.US)$ ⇨ Cosibelimab (CK-301)
$Neurocrine Biosciences (NBIX.US)$ ⇨ Crinecerfont capsule
$Bristol-Myers Squibb (BMY.US)$ ⇨ Opdivo® Subcutaneous (nivolumab + hyaluronidase)
$Neurocrine Biosciences (NBIX.US)$ ⇨ Crinece...

Kevin Travers

Nov 11 15:20

Columns Triple Treat Monday Sees Indecies Hit High Closes | Wall Street Today

Happy Monday, November 11th. The market climbed to a trifecta of closing highs for indices. The S&P 500 broke through 6k Friday and traded above the historic mark again Monday before the market pulled back in the afternoon.
Just past 4 pm ET the $S&P 500 Index (.SPX.US)$ traded +10 bps, the $Dow Jones Industrial Average (.DJI.US)$ climbed 69 bps, and the $Nasdaq Composite Index (.IXIC.US)$ climbed 0.06%.
MACRO
In macroecon...

Bitcoin's violent fluctuations: the entry point before Trump took office?